ID# 1902712 Real World Data for Spinal Cord Stimulation - Ethnic Minorities and Social Deprivation
No Thumbnail Available
Authors
Mehta V.
Ahmad A.
Bajaj G.
Poply, K.
Check for full-text access
Issue Date
2025
Type
Article
Language
Keywords
Alternative Title
Abstract
Introduction: Health inequality can be influenced by many factors including geography (i.e. access to healthcare services), language and communication barriers, patient preferences, health literacy, waiting times, perceived discrimination and physician bias. Patient ethnicity and language barrier are themes that can often underlie many of these factors. The 2021 UK census showed that 7.1% of the population had English as a second language, 1.5% spoke limited English and 0.3% were unable to speak English at all.1 34% of adults in the UK (Adult Chronic Pain Health Survey, 2017)2 suffer from some degree of chronic pain with similar prevalence in the non-English speaking patients suitable for neuromodulation therapies; however this has not been reported before. This is the first quantification of outcomes in patients with a language barrier highlighting key issues around SCS efficacy in this population. Method(s): After local approval, data from 494 patients (May 2021- June 2022) in a large tertiary inner- city hospital in the UK was reviewed. From this pool, 44 patients (9%) did not use English as their native language. 31 patients (70%) were suitable for SCS, highlighting demand for such services amongst ethnic minority groups. Data was analysed from 25 patients who underwent SCS and did not use English as their first language. Result(s): Of the 25 SCS patients implanted, n=4 had limited compliance with questionnaires, n=3 underwent revision, n=2 were explanted, (explant rate was 8%, which was greater than the centre's average explant rate 4%). The mean overall NRS decreased from 7.76 at baseline (n=23) to 4.18 at 12 months (p < 0.0001) (n=19) and mean EQ-5D-5L index scores increased from 0.23 at baseline (n=21) to 0.75 at 12 months (p < 0.0001) (n=17). Similar trends were also evident in the subset of patients that were implanted with a primary cell IPG (n=6). Conclusion(s): The statistically significant improvement in NRS and EQ-5D-5L scores at 12 months validates the need for therapy in this vulnerable group and highlights the growing demand for healthcare to be delivered to patients who cannot communicate in the language of their resident country. The explant rate (8%) and poor compliance with questionnaires (8%) in the ethnic minority population could potentially be attributed to lack of education or language barriers impeding effective dialogue with patients. Despite cultural factors, language barriers and beliefs, as possible confounders, we report successful outcomes at 12 months - highlighting the need for ethnic inclusivity in the context of SCS therapy. Copyright © 2025
Description
Citation
Publisher
License
Journal
Neuromodulation
Volume
Issue
North American Neuromodulation Society 28th Annual Meeting.